Clinical Trial: Phase II, Multicenter, Sacituzumab Govitecan in Recurrent Glioblastoma

Press/Media: Press / Media

PeriodSep 23 2020

Media coverage

2

Media coverage

  • TitleClinical Trial: Phase II, Multicenter, Sacituzumab Govitecan in Recurrent Glioblastoma
    Media name/outletHealth Daily Digest (Ht Media)
    CountryIndia
    Date9/23/20
    PersonsAndrew Brenner
  • TitleClinical Trial: Phase II, Multicenter, Sacituzumab Govitecan in Recurrent Glioblastoma
    Media name/outletUS Fed News
    CountryUnited States
    Date9/23/20
    PersonsAndrew Brenner